OakChart

NextPlat Corp

NXPLTechnology·Software - Application·USA·Nano·NASD·Nov 11 • 3:59 PM ET

8.29-0.06 (-0.72%)
2026-11-12 04:19 CET
Market cap
22.49 USD m
Revenue, TTM
48.29 USD m
Net income, TTM
-9.84 USD m
Free cash flow, TTM
-4.57 USD m
EPS diluted, TTM
-3.70
P/E
-
Compare

Price

NXPL against its 20, 50 and 200-day averages
2050200beatearnings
6.008.0010.00142K285KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NXPLclose 8.2920-day 8.5450-day 8.85200-day 6.878.2952w high

16.6% under the 52-week high of 9.94 on 2 Sep 2026. 52-week low 3.38 on 31 Mar 2026. Last 15 sessions, 31.5% high to low

Volume 0.90× normal · the line is the 50-bar volume average

Profile

NXPL
52-week range, 75% of the way up
3.389.94

NextPlat Corp. engages in the provision of satellite-based services and solutions for commercial, government and individual users. The firm's services include satellite communication solutions, emergency location systems, high-speed satellite internet and global asset and personnel monitoring, customized ground station systems and custom product design. It operates through the e-Commerce Operations and Healthcare Operations segments. The e-Commerce Operations segment refers to acquiring and leasing, primarily an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally. The Healthcare Operations segment refers TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, tele pharmacy services, anti-retroviral medications, and medication therapy management. The company was founded in 1997 and is headquartered in Hallandale Beach, FL.

Employees130
IPOMar 15, 1999
Beta1.91
ATR, 14d0.70
Rel volume0.90
Short float0.41%
Insider own48.36%
Inst own4.85%

Snapshot

6 groups

Valuation

Index-
Market Cap22.50M
Enterprise Value12.24M
Income-9.84M
Sales48.29M
Book/sh6.07
Cash/sh4.40
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees130
IPOMar 15, 1999

Ratios

P/E-
Forward P/E13.59
PEG-
P/S0.47
P/B1.37
P/C1.88
P/FCF-
EV/EBITDA-
EV/Sales0.25
Quick Ratio1.92
Current Ratio2.29
Debt/Eq0.10
LT Debt/Eq0.07
Option/ShortNo / Yes

Earnings

EPS (ttm)-3.70
EPS next Y0.61
EPS next Q-0.46
EPS this Y80.73%
EPS next Y171.76%
EPS next 5Y-
EPS past 3/5Y22.58% 46.76%
Sales past 3/5Y66.78% 57.03%
EPS Y/Y TTM19.42%
Sales Y/Y TTM-17.82%
EPS Q/Q92.28%
Sales Q/Q-10.26%
EarningsNov 12 BMO
EPS/Sales Surpr.76.19% 8.01%

Ownership

Insider Own48.36%
Insider Trans0.00%
Inst Own4.85%
Inst Trans-4.62%
ROA-28.78%
ROE-43.10%
ROIC-48.85%
Gross Margin4.28%
Oper. Margin-13.80%
Profit Margin-20.38%
SMA20-2.89%
SMA50-6.36%
SMA20020.71%
Trades-

Technical

Shs Outstand2.70M
Shs Float1.40M
Short Float0.41%
Short Ratio0.19
Short Interest0.01M
52W High9.94 -16.63%
52W Low3.38 145.63%
Volatility11.02% 9.56%
ATR (14)0.70
RSI (14)46.35
Beta1.91
Rel Volume0.90
Avg Volume30.11K
Volume27,061

Performance

Perf Week2.98%
Perf Month-7.89%
Perf Quarter2.22%
Perf Half Y29.33%
Perf YTD55.24%
Perf Year10.30%
Perf 3Y-55.43%
Perf 5Y-83.90%
Perf 10Y-99.70%
Recom1.00
Target Price12.00
Prev Close8.35
Price8.29
Change %-0.72%

Peers

Mkt cap
TickerCompanyMkt cap
HOURHour Loop Inc57.73M
PETSPetmed Express Inc23.09M
PTRNPattern Group Inc3.61B
SCNXScienture Holdings Inc4.99M
KVHIKVH Industries Inc132.85M
COSMCosmos Health Inc23.77M
LFMDLifeMD Inc85.80M
ATERAterian Inc240.34M
GSATGlobalstar Inc11.15B
POMPomdoctor Ltd13.84M

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B

News

latest 14 of 200
  • NextPlat's Promised Profit Turn Faces A Street That Still Expects A Deep Loss (Earnings Whispers)
  • NextPlat to Release Third Quarter 2026 Results on Thursday, November 12, 2026 (PR Newswire) +8.56%
  • NextPlat's PharmcoRx to Launch Automated Point-of-Care Prescription Dispensing Supporting Improved Patient Adherence and Pharmacy Growth (PR Newswire)
  • NextPlat Opens New Jacksonville Pharmacy Location to Offer High-Value Services for Patients and Local Healthcare Providers (PR Newswire)
  • NextPlat Completes Pensacola-Area Acquisition of Profitable Pharmacy, Accelerating Continued Healthcare Growth and Profitability (PR Newswire)
  • NextPlat Secures E-Commerce Agreement with Decathlon, a Leading Global Sporting-Goods Retailer, Opening New Consumer Sales Channel for Satellite Connectivity Products (PR Newswire)
  • NextPlat Corp (NXPL) (Q2 2026) Earnings Call Highlights: Record Margins and Strategic Shift ... (GuruFocus.com) +20.86%
  • NextPlat Reports 21% Sequential Quarterly Revenue Growth, 87% Reduction in Quarterly Net Loss to $144,000 and Record Gross Margin of Approximately 40% (PR Newswire)
  • NextPlat to Release Second Quarter 2026 Results on Thursday, August 13, 2026 (PR Newswire)
  • NextPlat's PharmcoRx Earns NABP Specialty Pharmacy Accreditation Strengthening its Credentials for New Opportunities with Healthcare Institutions and Providers (PR Newswire)
  • NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue (PR Newswire) -5.44%
  • NextPlat Corp (NXPL) Q1 2026 Earnings Call Highlights: Margin Expansion and Strategic Growth ... (GuruFocus.com)
  • NextPlat Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35% (PR Newswire)
  • NextPlat to Release First Quarter 2026 Results on Thursday, May 14, 2026 (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--0.460--13.001
2026Q22026-08-13-0.050-0.210-0.05011.8811.001
2026Q12026-05-14-0.420--0.4159.86--
2025Q32025-11-13-0.800--0.84113.75--
2025Q22025-08-14---0.07013.24--
2025Q12025-05-15---0.05014.53--
2024Q32024-11-14-2.200--2.22115.37--
2024Q22024-08-14---0.28016.99--
2024Q12024-05-15---0.08017.49--
2023Q32023-11-14--0.17015.29--
2023Q22023-08-14---3.00--
2023Q12023-05-15---2.90--
2022Q42023-04-03---2.60--
2022Q12022-05-17---3.58--
2021Q32021-11-15---2.25--
2026Q4--0.070--15.001

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-4.410--4.41054.32-
2026FY--0.850--49.74
2027FY-0.610--73.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-08-1310013.0013.0013.00
2026Q3S2026-06-2310013.0013.0013.00
2026Q3R2026-10-28100-0.46-0.46-0.46
2026Q3R2026-08-14101-0.46-0.46-0.46
2026Q3R2026-08-131000.000.000.00
2026Q3R2026-06-231000.000.000.00
2026Q3E2026-10-28100-0.46-0.46-0.46
2026Q3E2026-08-14101-0.46-0.46-0.46
2026Q3E2026-08-131000.000.000.00
2026Q3E2026-06-231000.000.000.00
2026Q2S2026-06-2310011.0011.0011.00
2026Q2R2026-06-23100-0.21-0.21-0.21
2026Q2E2026-06-23100-0.21-0.21-0.21
2026FYS2026-10-2810049.7449.7449.74

Estimate history

EPS, annual-6123.375-956.768-554.666-103.147-19.868-9.513-2.16-6.513-4.414-3.6981
Period201720182019202020212022202320242025TTM
EPS, quarterly-2.821-2.221-1.162-0.517-0.689-0.841-2.389-0.415-0.053
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual6.0055.7275.875.697.7411.7137.75666.08254.32248.29
Period201720182019202020212022202320242025TTM
Sales, quarterly16.98915.36715.63414.52513.2413.75212.8059.85511.881
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0010.0010.0020.0820.7051.441.8722.5962.6642.7
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.8971.8992.5962.5962.5962.6222.6642.692.7
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue48.2954.3266.0837.7611.717.745.695.875.73
Cost of Goods Sold Incl. D&A46.2354.7764.8735.2012.2811.796.365.655.94
Gross Profit2.07-0.441.212.56-0.57-4.05-0.670.22-0.22
Selling, General and Administrative Excl. Other8.738.3110.5811.896.642.571.361.330.91
Research and Development-------0.000.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-6.67-8.75-9.37-9.33-7.20-6.62-2.03-1.11-1.13
Interest Expense-0.060.080.080.021.471.020.290.00
Unusual Expense2.002.0013.7613.920.00-0.02-0.27-0.070.00
Net Income Before Taxes-8.60-10.46-22.45-22.29-7.33-8.11-2.76-1.38-1.19
Income Taxes0.010.000.070.030.090.000.000.000.01
Consolidated Net Income-8.61-10.46-22.53-12.41-9.16-8.11-2.76-1.38-1.19
Net Income From Continuing Operations-8.59-10.46-13.43-3.78-9.16-8.11-2.76-1.38-1.19
Net Income-9.84-11.71-13.43-3.78-9.16-8.11-2.76-1.18-1.19
EPS (Recurring)-3.12-3.89-1.843.41-9.51-19.90-110.18-576.09-956.77
EPS (Basic, Before Extraordinaries)-3.70-4.41-6.51-2.16-9.51-19.87-103.15-554.67-956.77
EPS (Diluted)-3.70-4.41-6.51-2.16-9.51-19.87-103.15-554.67-956.77
EBITDA-5.90-7.71-6.55-6.81-6.61-6.27-1.71-0.83-0.84
Non-Operating Income (Expense)0.100.350.761.04-0.11-0.040.02-0.04-0.06
Other After Tax Adjustments0.000.000.0011.350.000.000.000.000.00
Stock Option Compensation Expense0.900.641.264.272.353.760.830.000.22
Price To Sales Ratio0.380.260.340.761.041.710.780.050.03
Gross Margin4.28-0.821.836.78-4.83-52.38-11.773.67-3.76
Operating Margin-13.80-16.11-14.18-24.72-61.50-85.56-35.75-18.93-19.73
Net Margin-20.38-21.56-20.32-10.01-78.23-104.75-48.57-20.07-20.86
Shares Outstanding2.702.662.601.871.440.710.080.000.00
Market Capitalization22.4922.4928.0430.9012.1622.8510.610.362.25

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue11.889.8612.8013.7513.2414.5315.6315.37
Cost of Goods Sold Incl. D&A9.568.9513.8713.8413.0813.9716.9115.20
Gross Profit2.320.90-1.06-0.090.160.55-1.270.17
Selling, General and Administrative Excl. Other2.442.012.381.901.992.041.614.44
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.13-1.10-3.45-1.99-1.83-1.49-2.89-4.27
Interest Expense--0.020.010.010.020.020.02
Unusual Expense0.000.001.750.250.000.000.113.73
Net Income Before Taxes-0.10-1.13-5.16-2.21-1.76-1.33-3.04-7.62
Income Taxes0.050.00-0.01-0.030.030.01-0.020.04
Consolidated Net Income-0.14-1.13-5.15-2.19-1.79-1.34-3.02-7.66
Net Income From Continuing Operations-0.14-1.12-5.15-2.19-1.79-1.34-3.02-4.22
Net Income-0.14-1.12-6.39-2.19-1.79-1.34-3.02-4.22
EPS (Recurring)-0.05-0.42-1.93-0.77-0.69-0.52-1.13-0.85
EPS (Basic, Before Extraordinaries)-0.05-0.42-2.39-0.84-0.69-0.52-1.16-2.22
EPS (Diluted)-0.05-0.42-2.39-0.84-0.69-0.52-1.16-2.22
EBITDA0.02-0.95-3.22-1.74-1.56-1.19-2.59-3.79
Non-Operating Income (Expense)0.03-0.030.050.040.090.17-0.020.40
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.050.260.420.160.007.00-0.32
Price To Sales Ratio0.380.200.260.380.330.350.430.40
Gross Margin19.519.16-8.31-0.651.203.80-8.161.09
Operating Margin-1.07-11.19-26.92-14.46-13.81-10.22-18.47-27.79
Net Margin-1.21-11.34-49.94-15.89-13.51-9.25-19.30-27.44
Shares Outstanding2.702.692.662.622.602.602.601.90
Market Capitalization22.4910.0114.2221.7219.2921.5728.0426.78

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments13.7119.9626.3118.8917.270.730.080.140.23
Short Term Receivables6.596.8311.560.960.940.250.320.260.38
Inventories3.404.885.131.291.020.360.370.270.33
Other Current Assets0.460.400.640.050.150.030.120.050.13
Total Current Assets24.1632.0843.6421.1819.371.370.880.721.08
Net Property, Plant & Equipment2.694.225.582.101.071.161.421.521.76
Total Investments and Advances0.000.000.005.260.000.000.000.000.00
Intangible Assets0.580.6815.150.050.070.100.120.200.23
Deferred Tax Assets18.19----2.030.96--
Other Assets0.040.090.100.050.050.000.000.000.00
Total Assets45.6637.0864.4728.6420.574.673.392.443.06
Short Term Debt Incl. Current Port. of LT Debt0.570.790.860.270.080.190.050.040.01
Accounts Payable5.816.6012.141.190.850.750.900.630.66
Income Tax Payable0.010.050.140.120.060.020.020.010.01
Other Current Liabilities2.730.771.090.481.800.560.470.380.52
Total Current Liabilities9.138.2114.242.062.781.521.441.061.20
Long Term Debt0.921.472.150.810.250.550.340.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities18.19----2.030.96--
Other Liabilities0.000.000.000.000.000.000.000.000.00
Total Liabilities28.239.6816.382.863.034.102.751.061.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity17.3127.2832.1825.7817.530.570.641.381.86
Total Shareholders Equity17.3127.2832.1825.7817.530.570.641.381.86
Accumulated Minority Interest0.110.1115.900.000.000.000.000.000.00
Total Equity17.4227.4048.0925.7817.530.570.641.381.86
Total Liabilities & Stockholders Equity45.6637.0864.4728.6420.574.673.392.443.06
Book Value Per Share6.5010.5117.1917.9024.866.93263.871,102.781,487.94
Tangible Book Value Per Share6.2810.259.0917.8624.755.70212.31942.611,307.74
Full-Time Employees130180166195310129
Price to Book Ratio1.371.050.930.671.3018.770.561.639.26
Return on Assets-25.48-26.44-8.12-37.23-64.27-68.61-47.37-43.46-129.29
Return on Equity-47.57-45.15-13.04-42.30-89.61-458.69-136.72-73.79-188.96
Return on Invested Capital-57.41-46.69-11.01-34.46-45.59-247.23-140.38-86.65-211.84
Quick Ratio2.273.312.709.666.600.670.350.420.62
Current Ratio2.653.913.0710.296.970.910.610.680.90

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-8.61-10.46-22.53-12.41-9.16-8.11-2.76-1.38-1.19
Depreciation0.771.042.822.530.600.350.320.280.29
Other Funds (Non Cash)1.030.7715.559.434.765.161.590.360.22
Funds from Operations-6.80-8.65-4.15-0.45-3.81-2.59-0.85-0.74-0.69
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital2.272.52-1.31-3.150.21-1.500.010.080.10
Income Taxes Payable--0.04-0.090.040.040.04-0.000.01-0.00
Cash from Operating Activities-4.53-6.13-5.46-3.60-3.60-4.09-0.84-0.66-0.59
Capital Expenditures-0.04-0.07-0.19-0.65-0.72-0.23-0.03-0.07-0.03
Net Assets From Acquisitions0.000.00-1.090.00-1E-060.000.000.000.00
Sale of Fixed Assets and Businesses0.100.230.457.350.000.000.000.00-
Purchase or Sale of Investments0.000.000.00-1.51-7.000.000.000.000.00
Purchase of Investments-0.000.00-1.51-7.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.070.16-0.835.20-7.72-0.23-0.03-0.07-0.03
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-0.10-0.100.096.1813.0820.680.000.000.50
Repurchase of Common Pref Stock-0.10-0.100.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.096.1813.0820.680.000.000.50
Proceedsfrom Stock Options0.000.000.006.0013.0816.050.000.000.50
Issuance or Reduction of Debt, Net-0.15-0.12-0.14-0.32-0.060.201.510.650.03
Change in Long Term Debt-0.15-0.12-0.14-0.32-0.060.351.180.760.00
Issuance of Long Term Debt0.000.000.000.000.000.351.180.760.00
Reduction of Long Term Debt-0.15-0.12-0.14-0.32-0.060.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.00-0.01-0.070.050.011E-06
Other Financing Activities Uses0.000.000.000.00-0.01-0.07--0.00
Cash from Financing Activities-0.25-0.23-0.055.8613.0120.821.570.660.53
Exchange Rate Effect0.02-0.06-0.00-0.05-0.070.04-0.040.00-0.00
Net Change in Cash-4.70-6.25-6.357.421.6216.540.65-0.07-0.09
Free Cash Flow-4.57-6.20-5.65-4.24-4.32-4.32-0.87-0.73-0.62
Preferred Dividends (Cash Flow)--0.000.000.000.000.00--
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments11.9411.0113.7113.9316.6417.74
Short Term Receivables8.257.236.596.414.697.83
Inventories4.063.973.405.625.214.51
Other Current Assets0.901.050.460.260.310.40
Total Current Assets25.1523.2624.1626.2126.8630.48
Net Property, Plant & Equipment2.963.072.693.123.463.98
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.530.000.580.600.630.65
Deferred Tax Assets--18.19---
Other Assets0.040.590.040.080.090.09
Total Assets28.6726.9245.6630.0131.0335.20
Short Term Debt Incl. Current Port. of LT Debt0.380.540.570.610.590.70
Accounts Payable7.618.415.815.374.646.75
Income Tax Payable--0.010.070.100.07
Other Current Liabilities2.990.152.731.310.880.91
Total Current Liabilities10.989.099.137.366.218.42
Long Term Debt1.211.260.921.101.221.33
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--18.19---
Other Liabilities0.000.000.000.000.000.00
Total Liabilities12.1910.3428.238.477.429.75
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity16.3916.4717.3121.4323.4925.34
Total Shareholders Equity16.3916.4717.3121.4323.4925.34
Accumulated Minority Interest0.100.100.110.110.110.11
Total Equity16.4816.5717.4221.5523.6125.45
Total Liabilities & Stockholders Equity28.6726.9245.6630.0131.0335.20
Book Value Per Share6.076.136.508.179.059.76
Tangible Book Value Per Share5.876.136.287.948.819.51
Full-Time Employees--130---
Price to Book Ratio1.370.610.821.010.820.85
Return on Assets-28.78-32.96-25.48-23.44-25.13-27.70
Return on Equity-43.10-48.97-47.57-37.97-41.44-49.11
Return on Invested Capital-0.82-6.31-28.24-9.70-7.24-5.04
Quick Ratio1.922.122.272.803.493.08
Current Ratio2.292.562.653.564.333.62

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-0.14-1.13-5.15-2.19-1.79-1.34
Depreciation0.140.150.230.250.260.29
Other Funds (Non Cash)0.080.270.430.260.17-0.09
Funds from Operations0.08-0.71-4.49-1.68-1.35-1.13
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.01-1.874.18-1.050.31-0.93
Income Taxes Payable---0.06-0.030.040.01
Cash from Operating Activities1.08-2.58-0.30-2.73-1.04-2.06
Capital Expenditures0.000.00-0.040.00-0.01-0.02
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.100.130.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.00--0.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.00-0.040.100.12-0.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.00-0.000.000.00
Change in Capital Stock0.000.000.00-0.100.000.00
Repurchase of Common Pref Stock0.000.000.00-0.100.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.15-0.140.130.00-0.13-0.13
Change in Long Term Debt-0.15-0.140.130.00-0.13-0.13
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.15-0.140.130.00-0.13-0.13
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.15-0.140.13-0.10-0.13-0.13
Exchange Rate Effect-0.010.02-0.010.01-0.05-0.01
Net Change in Cash0.93-2.70-0.22-2.71-1.10-2.22
Free Cash Flow1.08-2.58-0.34-2.73-1.05-2.08

Revenue breakdown

E-Commerce2024: 13.79M 2025: 14.61M
Pharmacy 340B Contract2024: 10.38M 2025: 4.01M
Pharmacy Prescription and Other Revenue, Net of PBM Fees2024: 41.91M 2025: 35.70M
United States2024: 66.08M 2025: 54.32M
E-Commerce2024: 13.79M 2025: 14.61M
Healthcare Operations2024: 52.29M 2025: 39.71M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.41%0.0M1.4M33.35K
2026-10-150.40%0.0M1.4M33.94K
2026-09-300.30%0.0M1.0M39.22K
2026-09-150.33%0.0M1.0M43.95K
2026-08-310.53%0.0M1.0M43.67K
2026-08-140.45%0.0M1.0M38.02K
2026-07-310.64%0.0M1.0M28.98K
2026-07-150.53%0.0M1.0M26.80K
2026-06-300.77%0.0M1.0M25.55K
2026-06-150.79%0.0M1.5M24.18K
2026-05-291.68%0.0M2.0M98.60K
2026-05-152.31%0.0M1.5M136.72K
2026-04-302.04%0.0M1.5M138.37K
2026-04-152.30%0.0M1.5M138.41K
2026-03-311.76%0.0M1.4M135.16K
2026-03-137.00%0.1M1.4M131.42K
2026-02-273.80%0.1M1.4M52.34K
2026-02-131.16%0.0M1.4M11.40K
2026-01-301.37%0.0M1.4M18.36K
2026-01-151.44%0.0M1.4M61.82K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-068-KCurrent report2026-10-06SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-07-168-KCurrent report2026-07-14SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-248-KCurrent report2026-06-24SEC
2026-06-08424B3SEC
2026-06-04EFFECTEffectiveness filing by commission orderSEC
2026-06-03S-3/ASEC
2026-06-02CORRESPSEC
2026-06-0225-NSESEC
2026-05-1510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-05-13424B5SEC
2026-05-13UPLOADUpload SubmissionSEC
2026-05-06S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-04-30ARSAnnual report to security holders. 2025-12-31SEC
2026-04-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-24SEC
2026-04-298-KCurrent report2026-04-29SEC
2026-04-288-KCurrent report2026-04-27SEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
EverSource Wealth Advisors, LLC2.14%
VANGUARD CAPITAL MANAGEMENT LLC0.79%
GEODE CAPITAL MANAGEMENT, LLC0.76%
CITADEL ADVISORS LLC0.69%
VANGUARD FIDUCIARY TRUST CO0.33%
UBS Group AG0.11%
Tower Research Capital LLC0.02%
Vanguard Global Advisers, LLC0.01%
Caitong International Asset Management Co., Ltd0.00%
SBI Securities Co., Ltd.0.00%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.63%
Fidelity Extended Market Index Fund0.26%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.16%
Fidelity Total Market Index Fund0.15%
Fidelity Nasdaq Composite Index Fund0.13%
Fidelity Series Total Market Index Fund0.08%
Dimensional US Core Equity 1 ETF0.01%

OakChart. NXPL. Cached 15 minutes.

Some panels did not load: ratings, insider.